Records containing: Polycystic Kidney, Autosomal Dominant
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-27STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease
-
CLINICAL_TRIALS study record update · 2025-12-10Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD in Japan
-
CLINICAL_TRIALS study record update · 2025-06-03A Phase 1b, Double-Blind, Placebo-Controlled, Multiple Ascending Dose and an Open-Label Fixed-Dose Study in Patients With Autosomal Dominant Polycystic Kidney Disease to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RGLS8429
-
CLINICAL_TRIALS study record update · 2025-05-13Feasibility of Study of Empagliflozin in Patients With Autosomal Dominant Polycystic Kidney Disease
-
CLINICAL_TRIALS study record update · 2023-04-10Time Restricted Feeding in Overweight and Obese Adults With Autosomal Dominant Polycystic Kidney Disease
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-02-03PENGUIN: PErfusioN, OxyGen ConsUmptIon and ENergetics in ADPKD
-
CLINICAL_TRIALS study record update · 2022-11-09Multicenter, Randomized, Double-blind, Placebo-controlled Two Stage Study to Characterize the Efficacy, Safety, Tolerability and Pharmacokinetics of GZ/SAR402671 in Patients at Risk of Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)
-
CLINICAL_TRIALS study record update · 2022-11-08A Phase 1b/2a, Safety, Pharmacokinetic and Dose-Escalation Study of KD019 (Tesevatinib) in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
-
CLINICAL_TRIALS study record update · 2022-08-09Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease
-
CLINICAL_TRIALS study record update · 2022-04-25A Phase I, Single-Center, Open-label, Single Dose Pharmacokinetic and Tolerability Study of GZ402671 in Subjects With Mild, Moderate and Severe Renal Impairment, and in Matched Subjects With Normal Renal Function
-
CLINICAL_TRIALS study record update · 2022-03-03Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults With ADPKD
-
CLINICAL_TRIALS study record update · 2022-03-03Daily Caloric Restriction and Intermittent Fasting in Overweight and Obese Adults With Autosomal Dominant Polycystic Kidney Disease
-
CLINICAL_TRIALS study record update · 2021-09-23An International, Multicenter, Randomized Controlled Clinical Trial Assessing the Efficacy of Ursodeoxycholic Acid as a Volume Reducing Treatment in Symptomatic Polycystic Liver Disease
-
CLINICAL_TRIALS study record update · 2021-09-05Feasibility Study of Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease.
-
CLINICAL_TRIALS study record update · 2020-11-05Wishing to Decrease Aquaresis in ADPKD Patients Treated With a V2Ra; the Effect of Regulating Protein and Salt
-
CLINICAL_TRIALS study record update · 2020-04-30The Kidneys Ability to Concentrate and Dilute Urine in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) or Other Cause of Chronic Renal Disease Compared to Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2019-11-27A Phase 3b, Multi-center, Open-label Trial to Evaluate the Long Term Safety of Immediate-release Tolvaptan (OPC-41061, 30 mg to 120 mg/Day, Split Dose) in Subjects With Autosomal Dominant Polycystic Kidney Disease
-
CLINICAL_TRIALS study record update · 2019-07-17Endothelial Dysfunction in Autosomal Dominant Polycystic Kidney Disease
-
CLINICAL_TRIALS study record update · 2019-01-14Effect of Tolvaptan on Renal Plasma Flow (RPF) and Glomerular Filtration Rate (GFR) in ADPKD
-
CLINICAL_TRIALS study record update · 2018-11-06Pilot Study of RNA as a Biomarker for Autosomal Dominant Polycystic Kidney Disease
-
CLINICAL_TRIALS study record update · 2018-03-20The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Autosomal Dominant Polycystic Kidney Disease, During Basal Conditions and After Hypertonic Saline Infusion.
-
CLINICAL_TRIALS study record update · 2018-03-09Effect of Statin Therapy on Disease Progression in Autosomal Dominant Polycystic Kidney Disease
-
CLINICAL_TRIALS study record update · 2017-07-02A Phase 2, Multi-center, Open-label Study to Determine Long-term Safety, Tolerability and Efficacy of Split-dose Oral Regimens of Tolvaptan Tablets in a Range of 30 to 120 mg/d in Patients With Autosomal Dominant Polycystic Kidney Disease
-
CLINICAL_TRIALS study record update · 2015-10-28A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Of The Safety, Clinical Activity And Pharmacokinetics Of Bosutinib (PF-05208763) Versus Placebo In Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
-
CLINICAL_TRIALS study record update · 2012-11-21Pilot Study Of Long-Acting Octreotide (Octreotide LAR® Depot) In The Treatment Of Patients With Severe Polycystic Liver Disease